
Dolout P 37.5mg/325mg Tablet
Marketer
TTK Healthcare Ltd
Salt Composition
Tramadol (37.5mg) + Paracetamol (325mg)
Overview Dolout P 37.5mg/325mg Tablet
Combiflex (37.5mg/325mg) tablets offer dual-action pain relief for moderate to severe discomfort. Always follow your physician's prescribed dosage and regimen. Consumption with or without food is acceptable; however, consider taking it with food if stomach upset occurs. Consistent medication intake is crucial; discontinue use only under your doctor's guidance. Potential side effects, including nausea, vomiting, dry mouth, dizziness, and constipation, are generally mild and transient. Report any rashes or allergic reactions immediately. Pregnant women, those planning pregnancy, or breastfeeding individuals should consult their doctor before use.
Uses of Dolout P 37.5mg/325mg Tablet
Significant to intense pain
Major Benefits of Dolout P 37.5mg/325mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dolout P 37.5mg/325mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dolout P 37.5mg/325mg Tablet:
- Nausea
- Vomiting
- Constipation
- Dizziness
- Dryness in mouth
- Sleepiness
- Diarrhea
- Abdominal pain
- Dyspepsia
- Flatulence
- Headache
- Trembling
- Anxiety
- Sleep disorder
- Itching
How to use Dolout P 37.5mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dolout P 37.5mg/325mg tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Dolout P 37.5mg/325mg Tablet works:
Each Dolout P 37.5mg/325mg tablet combines tramadol and paracetamol to effectively manage intense pain. Tramadol, an opioid analgesic, reduces pain perception by interrupting pain signals to the brain. Paracetamol acts by inhibiting the production of pain-inducing chemical mediators.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dolout P 37.5mg/325mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Dolout P 37.5mg/325mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Consult your physician for advice.
Breast feedingSAFE IF PRESCRIBED
The use of Dolout P 37.5mg/325mg tablets during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, seek immediate medical advice should the baby exhibit excessive sleepiness, feeding difficulties, respiratory distress, or decreased muscle tone.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Dolout P 37.5mg/325mg Tablets.
KidneyCAUTION
Patients with impaired kidney function should use 37.5mg/325mg Dolout P tablets judiciously. Dosage modification for Dolout P 37.5mg/325mg tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Dolout P 37.5mg/325mg tablets cautiously, potentially requiring dosage modification. Consult a physician. Dolout P 37.5mg/325mg tablets are contraindicated for those with severe or active liver disease.
What if you forget to take Dolout P 37.5mg/325mg Tablet :
Should you forget to take a Dolout P 37.5mg/325mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Dolout P 37.5mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | Affirmative. |
| Treatment Category | Pain Relievers |
